Review of the toxicology, human exposure and safety assessment for bisphenol A diglycidylether (BADGE)

BADGE (whose chemical names are bisphenol A diglycidylether and 2,2-bis(4-(2,3-epoxypropyl)phenyl)propane) is the lowest molecular weight oligomer in commercial epoxy resins and the major component in commercial liquid epoxy resins. The major application areas for epoxy resins are protective coatings and civil engineering. Additional applications include printed circuit boards, composites, adhesives and tooling, while a relatively small amount of epoxy resins (<10%) finds use in protective coatings inside food and drink cans. The use of BADGE in food-contact applications was first regulated through EC Directive 2002/16/EC and amended in EC Directive 2004/13/EC with migration levels in food-contact applications being generally well below the regulatory thresholds. The paper discusses the commercial use of BADGE focusing on the current knowledge of human exposure from canned food applications. To assess the safety of this application, the exposure data are compared with no adverse effect levels (NOAEL) from various toxicological investigations with BADGE including reproductive and developmental assays, endocrine toxicity investigations, and sub-chronic and chronic assays. Consumer exposure to BADGE is almost exclusively from migration of BADGE from can coatings into food. Using a worst-case scenario that assumes BADGE migrates at the same level into all types of food, the estimated per capita daily intake for a 60-kg individual is approximately 0.16 μg kg−1 body weight day−1. A review of one- and two-generation reproduction studies and developmental investigations found no evidence of reproductive or endocrine toxicity, the upper ranges of dosing being determined by maternal toxicity. The lack of endocrine toxicity in the reproductive and developmental toxicological tests is supported by negative results from both in vivo and in vitro assays designed specifically to detect oestrogenic and androgenic properties of BADGE. An examination of data from sub-chronic and chronic toxicological studies support a NOAEL of 50 mg kg−1 body weight day−1 from the 90-day study, and a NOAEL of 15 mg kg−1 body weight day−1 (male rats) from the 2-year carcinogenicity study. Both NOAELS are considered appropriate for risk assessment. Comparing the estimated daily human intake of 0.16 μg kg−1 body weight day−1 with the NOAELS of 50 and 15 mg kg−1 body weight day−1 shows human exposure to BADGE from can coatings is between 250 000 and 100 000-fold lower than the NOAELs from the most sensitive toxicology tests. These large margins of safety together with lack of reproductive, developmental, endocrine and carcinogenic effects supports the continued use of BADGE for use in articles intended to come into contact with foodstuffs.

[1]  F. Olea-Serrano,et al.  Estrogenicity of resin-based composites and sealants used in dentistry. , 1996, Environmental health perspectives.

[2]  C. S. Weil,et al.  EXPERIMENTAL CARCINOGENICITY AND ACUTE TOXICITY OF REPRESENTATIVE EPOXIDES. , 1963, American Industrial Hygiene Association journal.

[3]  S. Gadd,et al.  Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  P. Boogaard,et al.  Dermal penetration and metabolism of five glycidyl ethers in human, rat and mouse skin , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  H. Kuster,et al.  Hydrolysis of bisphenol A diglycidylether by epoxide hydrolases in cytosolic and microsomal fractions of mouse liver and skin: inhibition by bis epoxycyclopentylether and the effects upon the covalent binding to mouse skin DNA. , 1989, Carcinogenesis.

[6]  J. Carroll,et al.  Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. , 2002, Cancer research.

[7]  J. Bierau,et al.  Metabolic inactivation of five glycidyl ethers in lung and liver of humans, rats and mice in vitro , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  E. Zeiger,et al.  Comparative mutagenicity of aliphatic epoxides in Salmonella. , 1986, Mutation research.

[9]  C. Hine,et al.  The toxicology of epoxy resins. , 1958, A.M.A. archives of industrial health.

[10]  P. Oldring,et al.  Estimates of per capita exposure to substances migrating from canned foods and beverages , 2002, Food additives and contaminants.

[11]  W. Lyman Handbook of chemical property estimation methods , 1982 .

[12]  I. J. Climie,et al.  Metabolism of the epoxy resin component 2,2-bis[4-(2,3-epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. Part II. Identification of metabolites in urine and faeces following a single oral dose of 14C-DGEBPA. , 1981, Xenobiotica; the fate of foreign compounds in biological systems.

[13]  T. Gardiner,et al.  Glycidyloxy compounds used in epoxy resin systems: a toxicology review. , 1992, Regulatory toxicology and pharmacology : RTP.

[14]  M. Metzler,et al.  The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. , 1998, Environmental health perspectives.

[15]  K. Satoh,et al.  Study on anti-androgenic effects of bisphenol a diglycidyl ether (BADGE), bisphenol F diglycidyl ether (BFDGE) and their derivatives using cells stably transfected with human androgen receptor, AR-EcoScreen. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  I. J. Climie,et al.  Metabolism of the epoxy resin component 2,2-bis[4](2,3]epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. Part I. A comparison of the fate of a single dermal application and of a single oral dose of 14C-DGEBPA. , 1981, Xenobiotica; the fate of foreign compounds in biological systems.

[17]  N. Ganguly,et al.  Effect of growth factors on proliferation of normal, borderline, and malignant breast epithelial cells. , 2000, Experimental and molecular pathology.

[18]  S. Gadd,et al.  Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors. , 1999, Toxicology and applied pharmacology.

[19]  C. Laymon A. study , 2018, Predication and Ontology.

[20]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[21]  H. Nakazawa,et al.  In vitro assay of hydrolysis and chlorohydroxy derivatives of bisphenol A diglycidyl ether for estrogenic activity. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  T. Zacharewski In Vitro Bioassays for Assessing Estrogenic Substances , 1997 .

[23]  C. Parsons THE AMERICAN CHEMICAL SOCIETY. , 1922, Science.

[24]  W. Breslin,et al.  Teratogenic evaluation of diglycidyl ether of bisphenol A (DGEBPA) in New Zealand white rabbits following dermal exposure. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[25]  V. Moudgil,et al.  Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells , 2002, Oncogene.